Bucillamine

DB12160InvestigationalSmall molecule

Bucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis.

Chemical structure of Bucillamine
Mechanism
Curator reviewed
Formula / weight
C7H13NO3S2 · 223.31 g/mol (avg)
Code names
DE-019 · SA96

Resolves to

Compound
UNIIR80LRA5WTFCAS65002-17-7ChEMBLCHEMBL80830ChEBI31312PubChem656604
Clinical / RWD
ATCM01CC02PharmGKBPA166123566
Structure
InChIKeyVUAFHZCUKUDDBC-BYPYZUCNSA-NSMILESCC(C)(S)C(=O)N[C@@H](CS)C(O)=O
Targets
Q16236NFE2L2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 20 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Bucillamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In